ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Granules India Earnings Call: Key Takeaways

Granules India achieved a landmark FY26 with revenue surpassing ₹50,000 Mn, driven by a structural shift toward high-margin Complex Generics and Peptide CDMO.

Why this was an Alfa AlertNot a filter event. Performance was strong but management did not explicitly state a >5% beat over prior internal guidance.
Highlights
Revenue growth20% YoY for FY26; 23% YoY for Q4FY26.
MarginsGross margin reached 65% (+355 bps YoY) due to product mix.
Demand visibilityStrong regulated-market momentum in North America and Europe.
Management confidenceHigh, citing 'landmark year' and structural margin expansion.

Growth

FY26 revenue grew 20% YoY to ₹53,656 Mn; EBITDA rose 25% to ₹11,851 Mn; PAT grew 19% to ₹5,950 Mn.

Outlook

Cumulative FY22-26 CAPEX of ₹23,107 Mn; targeting 50%+ FD revenue from Complex Gx; Senn Chemicals integration driving Peptide CDMO.

Risks

Gagillapur facility remediation is ongoing post-warning letter; working capital intensity rose in Q4 to support growth.

Source

Earnings Call filed with BSE, NSE: GRANULES. Summary written with AI assistance from the document.

Read the document ↗

Granules India Ltd: key numbers

Share price
₹799.25
Market cap
₹19,805 Cr
Revenue (annual)
₹5,366 Cr
Net profit (annual)
₹595.0 Cr
P/E (TTM)
27.8×Sector 43.8×
Promoter holding
37.39%-0.63% QoQ
FII holding
20.25%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Granules India Ltd

All →